These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 11120958
1. Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis. Tod M, Lokiec F, Bidault R, De Bony F, Petitjean O, Aujard Y. Antimicrob Agents Chemother; 2001 Jan; 45(1):150-7. PubMed ID: 11120958 [Abstract] [Full Text] [Related]
2. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age. Kimberlin DW, Jacobs RF, Weller S, van der Walt JS, Heitman CK, Man CY, Bradley JS. Clin Infect Dis; 2010 Jan 15; 50(2):221-8. PubMed ID: 20014952 [Abstract] [Full Text] [Related]
3. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S. Clin Ther; 2007 Jun 15; 29(6):1146-52. PubMed ID: 17692728 [Abstract] [Full Text] [Related]
4. Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. Anderson BJ, Pons G, Autret-Leca E, Allegaert K, Boccard E. Paediatr Anaesth; 2005 Apr 15; 15(4):282-92. PubMed ID: 15787918 [Abstract] [Full Text] [Related]
5. Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir. Zeng L, Nath CE, Blair EY, Shaw PJ, Stephen K, Earl JW, Coakley JC, McLachlan AJ. Antimicrob Agents Chemother; 2009 Jul 15; 53(7):2918-27. PubMed ID: 19414579 [Abstract] [Full Text] [Related]
6. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K. Cancer Chemother Pharmacol; 2003 Jun 15; 51(6):465-73. PubMed ID: 12698270 [Abstract] [Full Text] [Related]
7. Interaction between valproic acid and acyclovir after intravenous and oral administration in a rabbit model. van Jaarsveld MF, Walubo A, du Plessis JB. Basic Clin Pharmacol Toxicol; 2007 Dec 15; 101(6):434-40. PubMed ID: 18028106 [Abstract] [Full Text] [Related]
8. Multiple oral dosing of valacyclovir in horses and ponies. Garré B, Baert K, Nauwynck H, Deprez P, De Backer P, Croubels S. J Vet Pharmacol Ther; 2009 Jun 15; 32(3):207-12. PubMed ID: 19646083 [Abstract] [Full Text] [Related]
9. Acyclovir concentrations in the skin of humans after a single oral dose assessed by in vivo cutaneous microdialysis. Farfal S, Klimowicz A, Bielecka-Grzela S. Skin Res Technol; 2006 Nov 15; 12(4):228-34. PubMed ID: 17026652 [Abstract] [Full Text] [Related]
10. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis. Zhou H, Mayer PR, Wajdula J, Fatenejad S. J Clin Pharmacol; 2004 Nov 15; 44(11):1235-43. PubMed ID: 15496641 [Abstract] [Full Text] [Related]
11. An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children. Nadal D, Leverger G, Sokal EM, Floret D, Perel Y, Leibundgut K, Weller S. J Infect Dis; 2002 Oct 15; 186 Suppl 1():S123-30. PubMed ID: 12353197 [Abstract] [Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children. Tran A, Rey E, Pons G, Pariente-Khayat A, D'Athis P, Sallerin V, Dupont C. Clin Pharmacol Ther; 2002 May 15; 71(5):359-67. PubMed ID: 12011821 [Abstract] [Full Text] [Related]
14. Population pharmacokinetics of oral busulfan in children. Schiltmeyer B, Klingebiel T, Schwab M, Mürdter TE, Ritter CA, Jenke A, Ehninger G, Gruhn B, Würthwein G, Boos J, Hempel G. Cancer Chemother Pharmacol; 2003 Sep 15; 52(3):209-16. PubMed ID: 12811512 [Abstract] [Full Text] [Related]
15. Pharmacokinetics of valacyclovir in the adult horse. Maxwell LK, Bentz BG, Bourne DW, Erkert RS. J Vet Pharmacol Ther; 2008 Aug 15; 31(4):312-20. PubMed ID: 18638291 [Abstract] [Full Text] [Related]
16. Population pharmacokinetics of long-term oral amiodarone therapy. Pollak PT, Bouillon T, Shafer SL. Clin Pharmacol Ther; 2000 Jun 15; 67(6):642-52. PubMed ID: 10872646 [Abstract] [Full Text] [Related]
17. Amoxicillin pharmacokinetics in (preterm) infants aged 10 to 52 days: effect of postnatal age. Pullen J, Driessen M, Stolk LM, Degraeuwe PL, van Tiel FH, Neef C, Zimmermann LJ. Ther Drug Monit; 2007 Jun 15; 29(3):376-80. PubMed ID: 17529898 [Abstract] [Full Text] [Related]
18. Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia. Läer S, Elshoff JP, Meibohm B, Weil J, Mir TS, Zhang W, Hulpke-Wette M. J Am Coll Cardiol; 2005 Oct 04; 46(7):1322-30. PubMed ID: 16198851 [Abstract] [Full Text] [Related]
19. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E, Cloyd J, Critchley D, Fuseau E. Epilepsia; 2008 Jul 04; 49(7):1123-41. PubMed ID: 18503564 [Abstract] [Full Text] [Related]
20. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy. Eisen D, Essell J, Broun ER, Sigmund D, DeVoe M. Bone Marrow Transplant; 2003 Jan 04; 31(1):51-5. PubMed ID: 12621507 [Abstract] [Full Text] [Related] Page: [Next] [New Search]